Thornton, Emma <br/><br/>
The NK1 receptor antagonist N-acetyl-L-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model.  [electronic resource] 

 -  Parkinsonism & related disorders  May 2014 
 - 508-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5126 
<br/><br/><label>Standard No.: </label>10.1016/j.parkreldis.2014.02.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenergic Agents--toxicity<br/>Analysis of Variance<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Dose-Response Relationship, Drug<br/>Dyskinesia, Drug-Induced--drug therapy<br/>Functional Laterality--drug effects<br/>Levodopa--adverse effects<br/>Male<br/>Medial Forebrain Bundle--injuries<br/>Motor Activity--drug effects<br/>Oxidopamine--toxicity<br/>Parkinsonian Disorders--chemically induced<br/>Proto-Oncogene Proteins c-fos--metabolism<br/>Rats<br/>Rats, Sprague-Dawley<br/>Time Factors<br/>Tryptophan--analogs & derivatives<br/>Tyrosine 3-Monooxygenase--metabolism